本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Regulus Therapeutics Inc

8.16
0.0000
成交量:- -
成交額:7,591.12萬
市值:5.65億
市盈率:-11.28
高:8.16
開:8.16
低:8.16
收:8.16
52周最高:8.35
52周最低:0.8301
股本:6,923.41萬
流通股本:5,293.84萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.7233
每股收益(LYR):-0.8227
淨資產收益率:-53.82%
總資產收益率:-34.23%
市淨率:8.18
市盈率(LYR):-9.92

資料載入中...

2024/05/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/17

SEC問詢函

Form CORRESP - Correspondence
2024/03/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/06

SEC問詢函

Form CORRESP - Correspondence
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report